--- title: "Zhaoke Ophthalmology (6622) stock: news and investor profile" url: "https://aibio.space/companies/zhaoke-ophthalmology/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Zhaoke Ophthalmology Ltd. (HKEX: 6622), China. The directory classifies it as Pharmaceuticals: Major." --- 6622 Zhaoke Ophthalmology Ltd. HKEX · China # Zhaoke Ophthalmology (6622) news Zhaoke Ophthalmology Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6622, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Zhaoke Ophthalmology news We have not published a story on Zhaoke Ophthalmology yet. When there is news, it will appear here. ## Zhaoke Ophthalmology at a glance - **Ticker**: 6622 - **Listing**: HKEX - **Country**: China ### Related companies - [Livzon Pharmaceutical Group](https://aibio.space/companies/livzon-pharmaceutical/) SZSE: 000513 - [BGM Group](https://aibio.space/companies/bgm/) NASDAQ: BGM - [Zhejiang Int'l Group Co.](https://aibio.space/companies/zhejiang-int-l/) SZSE: 000411 - [Zhejiang Shapuaisi Pharmaceutical Co.](https://aibio.space/companies/zhejiang-shapuaisi-pharmaceutical/) SSE: 603168 - [Yifan Pharmaceutical Co.](https://aibio.space/companies/yifan-pharmaceutical/) SZSE: 002019 - [Jiangsu Aidea Pharmaceutical Group Co.](https://aibio.space/companies/jiangsu-aidea-pharmaceutical/) SSE: 688488 - [Guobang Pharma](https://aibio.space/companies/guobang-pharma/) SSE: 605507 - [Tianjin Ringpu Bio-technology Co.](https://aibio.space/companies/tianjin-ringpu-bio-technology/) SZSE: 300119 ### Also on HKEX - [CPBIO Holding Company](https://aibio.space/companies/cpbio/) 3839 - [Beijing Luzhu Biotechnology Co.](https://aibio.space/companies/beijing-luzhu-biotechnology/) 2480 - [Everest Medicines](https://aibio.space/companies/everest-medicines/) 1952 - [Hansoh Pharmaceutical Group Company](https://aibio.space/companies/hansoh-pharmaceutical/) 3692 - [Zhejiang Laifual Drive Co.](https://aibio.space/companies/zhejiang-laifual-drive/) 3952 - [China Resources Pharmaceutical Group](https://aibio.space/companies/china-resources-pharmaceutical/) 3320 ## Questions about Zhaoke Ophthalmology What is the ticker symbol of Zhaoke Ophthalmology? Zhaoke Ophthalmology Ltd. trades under the ticker 6622 on HKEX. Where is Zhaoke Ophthalmology listed? Zhaoke Ophthalmology Ltd. is listed on HKEX. Which country or territory is Zhaoke Ophthalmology listed under? Our directory records Zhaoke Ophthalmology Ltd. under China. What does Zhaoke Ophthalmology do? Our directory classifies Zhaoke Ophthalmology Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Zhaoke Ophthalmology? The ISIN recorded for Zhaoke Ophthalmology Ltd. is KYG989M51017. Does aibio.space cover Zhaoke Ophthalmology? aibio.space lists Zhaoke Ophthalmology Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Zhaoke Ophthalmology? Companies in our directory listed in the same country and business area as Zhaoke Ophthalmology: Livzon Pharmaceutical Group, BGM Group, Zhejiang Int'l Group Co., Zhejiang Shapuaisi Pharmaceutical Co., Yifan Pharmaceutical Co., Jiangsu Aidea Pharmaceutical Group Co.. ## Investor discussion: Zhaoke Ophthalmology Members talk about Zhaoke Ophthalmology (6622). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Zhaoke Ophthalmology, newest first. Each line links the filing it comes from. 1. 2025-03-24 Mergers Transaction under the Listing Rules: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 AND DISCLOSEABLE TRANSACTION IN RELATION TO SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0324/2025032401488.pdf) ## Press releases Headlines of Zhaoke Ophthalmology's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-27 HKEXnews [VOLUNTARY ANNOUNCEMENT - ZHAOKE OPHTHALMOLOGY'S MANUFACTURING FACILITY OBTAINS GMP CERTIFICATION FROM THE THERAPEUTIC GOODS ADMINISTRATION OF AUSTRALIA ("TGA")](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1027/2026102700062.pdf) 2. 2026-09-30 HKEXnews [NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0930/2026093000367.pdf) 3. 2026-09-30 HKEXnews [NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0930/2026093000363.pdf) 4. 2026-09-04 HKEXnews [VOLUNTARY ANNOUNCEMENT - CARBACHOL AND BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION (YUVEZZI) MET THE PRIMARY ENDPOINT IN THE PHASE II STUDY IN CHINESE PATIENTS WITH PRESBYOPIA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0904/2026090401773.pdf) 5. 2026-08-28 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082803006.pdf) 6. 2026-08-12 HKEXnews [VOLUNTARY ANNOUNCEMENT - ENTERING AN EXCLUSIVE DISTRIBUTION AND PROMOTION AGREEMENT WITH PHARMENTUM BIOPHARMA TO COMMERCIALIZE EPINASTINE HYDROCHLORIDE EYE DROPS IN CHINA (EXCLUDING HONG KONG, MACAU AND TAIWAN)](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0812/2026081200564.pdf) 7. 2026-07-20 HKEXnews [VOLUNTARY ANNOUNCEMENT - INNOVATIVE PRESBYOPIA DRUG YUVEZZI APPROVED BY THE PHARMACEUTICAL ADMINISTRATION BUREAU OF THE GOVERNMENT OF THE MACAU SPECIAL ADMINISTRATIVE REGION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0720/2026072000247.pdf) 8. 2026-07-13 HKEXnews [VOLUNTARY ANNOUNCEMENT - ENTERED INTO A DEFINITIVE AGREEMENT FOR THE ACQUISITION OF THE GLOBAL RIGHTS TO NVK002 (ATROPINE SULFATE EYE DROPS)](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0713/2026071300282.pdf) 9. 2026-07-07 HKEXnews [VOLUNTARY ANNOUNCEMENT - INNOVATIVE PRESBYOPIA DRUG YUVEZZI APPROVED FOR USE AT BOAO SUPER HOSPITAL AS A CLINICALLY URGENT IMPORTED DRUG](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0707/2026070700257.pdf) 10. 2026-06-15 HKEXnews [VOLUNTARY ANNOUNCEMENT - REGISTRATION APPLICATION FOR ATROPINE SULFATE EYE DROPS (0.02 STRENGTH) ACCEPTED FOR EVALUATION BY AUSTRALIAS THERAPEUTIC GOODS ADMINISTRATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0615/2026061500251.pdf) 11. 2026-06-08 HKEXnews [VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0608/2026060801542.pdf) 12. 2026-06-05 HKEXnews [VOLUNTARY ANNOUNCEMENT - ENTERING INTO DISTRIBUTION AND SUPPLY AGREEMENT WITH PT. ERELA TO COMMERCIALIZE CsA OPHTHALMIC GEL IN INDONESIA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060500293.pdf) 13. 2026-05-27 HKEXnews [AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0527/2026052700379.pdf) 14. 2026-05-15 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 15, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0515/2026051501549.pdf) 15. 2026-04-30 HKEXnews [CONTINUING CONNECTED TRANSACTIONS IN RELATION TO RENEWAL OF MASTER CMO SERVICE AGREEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0430/2026043002909.pdf) 16. 2026-04-23 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042301154.pdf) 17. 2026-04-15 HKEXnews [PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0415/2026041500780.pdf) 18. 2026-03-25 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032501293.pdf) 19. 2026-01-29 HKEXnews [VOLUNTARY ANNOUNCEMENT - ZHAOKE OPHTHALMOLOGY'S PARTNER TENPOINT THERAPEUTICS, LTD. RECEIVES FDA APPROVAL FOR BRIMOCHOL PF IN THE UNITED STATES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0129/2026012901175.pdf) 20. 2026-01-26 HKEXnews [VOLUNTARY ANNOUNCEMENT - ADVANCING COMMERCIALIZATION OF BRIMOCHOL PF FOR PRESBYOPIA IN SINGAPORE AND VIETNAM THROUGH PARTNERSHIPS WITH AFT AND SENJU](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0126/2026012600476.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:6622 on TradingView](https://www.tradingview.com/symbols/HKEX-6622/). ## Listing details Zhaoke Ophthalmology Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6622, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Zhaoke Ophthalmology Ltd. - **Ticker**: 6622 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG989M51017 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-6622/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/zhaoke-ophthalmology/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Zhaoke Ophthalmology (6622) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/zhaoke-ophthalmology/